Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
Clinical trial NCT07353216 · RECRUITING
Trial details
- NCT number
- NCT07353216
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.